Abstract
Objective
Prevalence of colonoscopy (CS) is an important countermeasure against colorectal cancer (CRC). In this study, we used large-scale data for a comparison of CS with esophagogastroduodenoscopy (EGD) in Japan.
Methods
This was a retrospective descriptive study. Commercially anonymized patient data were collected from various health insurance societies (JMDC, Inc. Tokyo, Japan) generated from the insurance registry, receipts (inpatient, outpatient, and prescription), and health checkup data. The data also included healthy subjects who had never been examined in a hospital. The data of 2,760,048 persons who were 50–75 years old during January 2012–December 2019 were extracted from the original data source. The annual rate, the prevalence rate (frequency of those undergoing at least one endoscopy during the period), and the percentage of repeaters (undergoing endoscopy at least twice during the period) of CS were calculated and compared to those of EGD.
Results
The annual rates in 2012/2015/2019 were 3.4%/4.5%/5.3% for CS, respectively, and increased gradually from 2012 to 2019. Those rates were 7.0%/7.9%/7.4% for EGD, respectively, and did not increase. The prevalence rates of CS and EGD were 25.3% and 36.2%, respectively, among the 137,246 participants over 8 years. The prevalence rates of individuals in their 50 s/60 s/70 s were 23.0%/25.9%/31.4% for CS and 33.0%/37.6%/40.7% for EGD, respectively. The proportions of males/females were 27.9%/20.7% for CS, and 36.4%/35.8% for EGD, respectively. The repeat rates of CS and EGD were 40.3% and 44.8%, respectively, over 8 years.
Conclusions
Using large-scale data, we determined the status of CS and EGD in Japan.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–105.
Doubeni CA, Weinmann S, Adams K, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013;158:312–20.
Davidson KW, Barry MJ, United States Preventive Services Task Force, et al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325:1965–77.
Centers for Disease Control and Prevention [Internet]. National health interview survey. [Cited 2023 April 8]. Available from: https://www.cdc.gov/nchs/data/databriefs/db274.pdf.
International Agency for Research on Cancer, World Health Organization [Internet]. Cancer over time. [Cited 2023 April 14] Available from: https://gco.iarc.fr/overtime/en/dataviz/trends?populations=84001&sexes=1_2&cancers=106&multiple_populations=0&mode=cancer&group_populations=1&multiple_cancers=1&key=total&types=1
Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73.
Cancer statistics [Internet]. Cancer Information Service, National Cancer Center (National Cancer Registry, Ministry of Health, Labour and Welfare). [Cited 2022 December 26]. Available from https://ganjoho.jp/reg_stat/statistics/data/dl/index.html.
Ross WA. Colorectal cancer screening in evolution: Japan and the USA. J Gastroenterol Hepatol. 2010;25:S49-56.
Yoneda M, Yamamoto T, Honda Y, et al. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. J Gastroenterol. 2021;56:1022–32.
Umemura T, Wattanakamolkul K, Nakayama Y, et al. Real-world epidemiology, clinical and economic burden of chronic hepatitis B in Japan: a retrospective study using JMDC claims database. Infect Dis Ther. 2023;12:1337–49.
Yoshida N, Mano Y, Matsuda T, et al. Complications of colonoscopy in Japan: an analysis using large-scale health insurance claims data. J Gastroenterol Hepatol. 2021;36:2745–53.
Yoshida N, Maeda-Minami A, Ishikawa H, et al. Analysis of the development of gastric cancer after resecting colorectal lesions using large-scale health insurance claims data. J Gastroenterol. 2023;58:1105–13.
Helsingen LM, Kalager M. Colorectal cancer screening—approach, evidence, and future directions. NEJM Evidence. 2022;1:EVIDra2100035.
Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23:3632–42.
Helsingen LM, Vandvik PO, Jodal HC, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline. BMJ. 2019;367: l5515.
Kaminski MF, Kraszewska E, Rupinski M, Laskowska M, Wieszczy P, Regula J. Design of the polish colonoscopy screening program: a randomized health services study. Endoscopy. 2015;47:1144–50.
von Karsa L, Patnick J, European Colorectal Cancer Screening Guidelines Working Group, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45:51–9.
Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;152:1217-37.e3.
Bretthauer M, Kaminski MF, Løberg M, et al. Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med. 2016;176:894–902.
Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697–706.
Bretthauer M, Løberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022;387:1547–56.
Senore C, Inadomi J, Segnan N, Bellisario C, Hassan C. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64:1158–77.
Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012;143:844–57.
Hassan C, Quintero E, Dumonceau JM, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2013;45:842–51.
Matsuda T, Fujii T, Sano Y, et al. Randomised comparison of postpolypectomy surveillance intervals following a two-round baseline colonoscopy: the Japan Polyp Study Workgroup. Gut. 2021;70:1469–78.
Martínez ME, Thompson P, Messer K, et al. One-year risk for advanced colorectal neoplasia: U.S. versus U.K. risk-stratification guidelines. Ann Intern Med. 2012;157:856–64.
Yoshida N, Naito Y, Siah KT, et al. High incidence of metachronous advanced adenoma and cancer after endoscopic resection of colon polyps ≥20 mm in size. Dig Endosc. 2016;28:194–202.
Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1–42.
The ASCO Post [Internet]. National Comprehensive Cancer Network, ed. Colon Cancer. version 3. 2014, NCCN clinical practice guideline in oncology [Cited 2023 April 20]. Available from: https://ascopost.com/issues/may-15-2014/nccn-clinical-practice-guidelines-in-oncology-2014-updates/
Acknowledgements
We thank all the members of the Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, for their assistance with this study.
Funding
None.
Author information
Authors and Affiliations
Contributions
NY and HI: designed this study, AM-M, YM: performed statistical analysis, and MM, YT, RK, HH, KI, RH, OD, and YI: provided comprehensive comments about the results. All authors reviewed the paper and agreed with the contents.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yoshida, N., Maeda-Minami, A., Ishikawa, H. et al. Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy. J Gastroenterol (2024). https://doi.org/10.1007/s00535-024-02087-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00535-024-02087-x